02580nam 2200601 450 991046061780332120200520144314.00-309-31001-6(CKB)3710000000336166(EBL)3379407(SSID)ssj0001467018(PQKBManifestationID)11892276(PQKBTitleCode)TC0001467018(PQKBWorkID)11504063(PQKB)11321513(MiAaPQ)EBC3379407(Au-PeEL)EBL3379407(CaPaEBR)ebr11003355(OCoLC)904080937(EXLCZ)99371000000033616620150121h20142014 uy 0engurcnu||||||||txtccrCharacterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products workshop summary /Denise Caruso, Rebecca A. English, Anne B. ClaiborneWashington, District of Columbia :The National Academies Press,2014.©20141 online resource (150 p.)Description based upon print version of record.0-309-31000-8 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Contents""; ""Boxes, Figures, and Table""; ""Acronyms""; ""1 Introduction""; ""2 Identifying and Characterizing Uncertainty""; ""3 The Regulators Challenge""; ""4 Basic Methodologies and Applications for Understanding and Evaluating Uncertainty""; ""5 Communicating Uncertainty""; ""6 Final Reflections on Ways to Characterize and Communicate Uncertainty""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: FDA Case Studies""; ""Appendix C: Bibliography""; ""Appendix D: Participant Biographies""Risk assessmentCongressesCommunicationCongressesElectronic books.Risk assessmentCommunication363.1Caruso Denise928102English Rebecca A.Claiborne Anne B.Board on Health Sciences Policy.Institute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.Institute of Medicine (U.S.)MiAaPQMiAaPQMiAaPQBOOK9910460617803321Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products2085694UNINA